[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-355023-105":59,"doc-detail-355023-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","metabolic-characteristics-in-hepatocellular-carcinoma-amino-acid-metabolic-reprogramming","Metabolic characteristics in hepatocellular carcinoma: amino acid metabolic reprogramming","","Hepatocellular carcinoma (HCC) is a common primary liver cancer and a major contributor to cancer-related deaths globally due to its aggressive behavior and therapy resistance. As the liver’s primary metabolic organ, carcinogenesis drives extensive metabolic reprogramming across carbohydrates, lipids, and amino acids. In particular, disrupted amino acid metabolism supports HCC initiation and progression. This review analyzes changes in aromatic amino acids, branched-chain amino acids, glutamine, and additional amino acid pathways (serine, arginine, methionine), including expression patterns of related metabolic enzymes, and discusses therapeutic options with clinical relevance.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/metabolic-characteristics-in-hepatocellular-carcinoma-amino-acid-metabolic-reprogramming/355023/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/metabolic-characteristics-in-hepatocellular-carcinoma-amino-acid-metabolic-reprogramming/355023.png","ImageObject",300,407,{"name":92,"@type":93},"Hazel","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-04","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",13,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"Why is hepatocellular carcinoma (HCC) difficult to manage clinically?","Question",{"text":113,"@type":114},"HCC is aggressive and often resistant to therapies, making early detection and durable treatment challenging and worsening overall prognosis.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"What types of amino acid metabolic alterations does the review focus on?",{"text":118,"@type":114},"The review emphasizes aromatic amino acid metabolism, branched-chain amino acids (BCAAs), glutamine metabolism, and other pathways including serine, arginine, and methionine.",{"name":120,"@type":111,"acceptedAnswer":121},"How does the review connect amino acid metabolism to HCC progression?",{"text":122,"@type":114},"It explains that disruptions in amino acid metabolism help sustain malignant characteristics, contributing to the initiation and progression of HCC while altering relevant metabolic enzyme expression.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},355023,1790177093,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},137441390410,"https://ap-avatar.wpscdn.com/avatar/2000252f4ab5702993?_k=1776741390130283984","Zhou et al. Molecular Cancer (2026) 25:25 [https://doi.org/10.1186/s12943-025-02492-7](https://doi.org/10.1186/s12943-025-02492-7)  \nMolecular Cancer  \nREVIEW Open Access  \nMetabolic characteristics in hepatocellular carcinoma: amino acid metabolic reprogramming  \nRan Zhou1, Yuejun Li3, Guanghui Li1, Yan Li1, Lie Luo1, Bin Wang1,2* and Liping Wang1*  \nAbstract  \nHepatocellular carcinoma (HCC) is a common type of primary liver cancer and is considered the third leading cause of cancer-related deaths worldwide. The high aggressiveness and resistance to therapies exhibited by HCC present significant challenges to global public health. As the primary metabolic organ in the human body, the liver undergoes substantial metabolic reprogramming during carcinogenesis, affecting various metabolic pathways including those involved in carbohydrates, lipids, and amino acids. Notably, disruptions in amino acid metabolism play a critical role in the initiation and progression of HCC, helping to sustain its malignant characteristics. This review aims to provide an in-depth analysis of the alterations observed in aromatic amino acids metabolism, branched chain amino acids (BCAAs) metabolism, glutamine metabolism, and other amino acid metabolism processes, including serine, arginine, and methionine, along with the expression patterns of associated metabolic enzymes. Furthermore, it discusses potential therapeutic approaches and their clinical relevance, offering insightsand strategies for improving HCC diagnosis and treatment in the future.  \nKeywords Hepatocellular carcinoma, Metabolic reprogramming, Amino acid metabolism  \nIntroduction  \nHepatocellular carcinoma (HCC), a malignant tumor of the liver, is a primary cancer originating from hepatocytes and is one of the most common malignancies worldwide [1, 2]. According to the 2022 global cancer statistics, primary liver cancer is the sixth most frequently diagnosed cancer worldwide and the third leading cause  \n*Correspondence: Bin Wang [wangbin@huashan.org.cn](wangbin@huashan.org.cn)[ ](wangbin@huashan.org.cn)Liping Wang [lpwang14@fudan.edu.cn](lpwang14@fudan.edu.cn)  \n1Department of Pharmacy, Jing’an District Central Hospital of Shanghai, Fudan University, Shanghai 200040, China  \n2Department of Pharmacy, Huashan Hospital, Fudan University, Shanghai 200040, China  \n3Department of Stomatology, Huashan Hospital, Fudan University, Shanghai 200040, China  \nof cancer-related mortality [3]. The elevated mortality rate of HCC can be attributed to difficulties in early detection, high metastasis rates in later stages, and the absence of safe and effective treatment options [4, 5]. Currently, the main risk factors for HCC include chronic infection with hepatitis B virus (HBV) and hepatitis C virus (HCV), aflatoxin exposure, alcohol abuse, and nonalcoholic fatty liver disease (NAFLD) related to diabetes or obesity [6–9]. However, with the widespread implementation of HBV vaccination and the use of antiviral therapies, the risk of HCC development related to viral liver diseases has significantly decreased [1]. In contrast, the rapid rise in NAFLD-related cases in recent years has made metabolic disorders an increasingly common risk factor for HCC development [10]. The reclassification of NAFLD to metabolic dysfunction-associated fatty liver disease (MAFLD) has attracted significant attention  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in ","cbCaineB5PGOcTxW","https://ap.wps.com/l/cbCaineB5PGOcTxW","pdf",3746298,34,"English","# Abstract\n# Introduction","[{\"question\":\"Why is hepatocellular carcinoma (HCC) difficult to manage clinically?\",\"answer\":\"HCC is aggressive and often resistant to therapies, making early detection and durable treatment challenging and worsening overall prognosis.\"},{\"question\":\"What types of amino acid metabolic alterations does the review focus on?\",\"answer\":\"The review emphasizes aromatic amino acid metabolism, branched-chain amino acids (BCAAs), glutamine metabolism, and other pathways including serine, arginine, and methionine.\"},{\"question\":\"How does the review connect amino acid metabolism to HCC progression?\",\"answer\":\"It explains that disruptions in amino acid metabolism help sustain malignant characteristics, contributing to the initiation and progression of HCC while altering relevant metabolic enzyme expression.\"}]","Metabolic characteristics in hepatocellular carcinoma: amino acid metabolic reprogramming | PDF",1790115457,86,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e06095c993bfcff72da8cfadfa569f10.webp",983,1310,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0703f505223b5b59fd9729bc7a2d895e.webp",982,1309,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2fee52aaf59ba7e5f9aeae27e65ccd73.webp",981,1308,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f5b9eb1f0f138b7d8c7eaec0a252015f.webp",980,1306]